Meituan's entry into the medical aesthetics industry has made many people uncomfortable and was considered by industry insiders as a "forced entry".
Shanxi Jinbo Biotechnology Co., Ltd., a supplier in the medical aesthetics industry, directly criticized Meituan.
On September 20, Jinbo Biotechnology (832982.BJ) published an article titled "To Our Consumers" on its official WeChat account, mentioning that "in the 'Billion Subsidy' campaign launched by Meituan's medical aesthetics section, VEYIYO was included in the 'Hydrating Treatment' promotion. However, some merchants participating in this promotion were not authorized by our company and did not purchase products through our authorized channels."$MEITUAN(03690.HK)
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
